K. Kotoh

发表

T1ρ Relaxation of the liver: A potential biomarker of liver function

H. Honda, T. Okuaki, Y. Takayama, 2015, Journal of magnetic resonance imaging : JMRI.

Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

K. Kotoh, M. Nakamuta, M. Kohjima, 2005, International journal of molecular medicine.

SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.

K. Kotoh, R. Takayanagi, M. Nakamuta, 2008, International journal of molecular medicine.

LOW‐FREQUENCY OF BACTEREMIA AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION OF THE STOMACH

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2011, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

Low-grade elevation of fibrinogen-degradation products is an important parameter to identify acute presentation of autoimmune hepatitis

K. Kotoh, Masaki Kato, Hideo Suzuki, 2016, Scandinavian journal of gastroenterology.

Potential role of branched‐chain amino acids in glucose metabolism through the accelerated induction of the glucose‐sensing apparatus in the liver

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2011, Journal of cellular biochemistry.

Short-Term Intensive Treatment for Donors with Hepatic Steatosis in Living-Donor Liver Transplantation

Y. Maehara, K. Kotoh, M. Shimada, 2005, Transplantation.

The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C.

Y. Maehara, K. Kotoh, T. Ikegami, 2009, Transplantation proceedings.

Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection.

H. Nomura, J. Hayashi, K. Kotoh, 2014, Antiviral research.

Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats

K. Kotoh, R. Takayanagi, M. Nakamuta, 2013, International journal of molecular medicine.

A new treatment strategy for acute liver failure.

K. Kotoh, M. Nakamuta, M. Kohjima, 2010, World journal of hepatology.

Body surface area is an independent factor contributing to the effects of lamivudine treatment.

H. Nomura, J. Hayashi, K. Kotoh, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2012, Journal of Gastroenterology.

Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study.

K. Kotoh, M. Nakashima, M. Nakamuta, 2008, International journal of molecular medicine.

High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen‐activated protein kinase

K. Kotoh, M. Nakamuta, M. Kohjima, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

K. Kotoh, M. Nakashima, M. Nakamuta, 2014, World journal of gastroenterology.

Primary hepatic carcinoid tumor: case report and review of 53 cases.

K. Kotoh, H. Nawata, M. Nakamuta, 2001, Medical science monitor : international medical journal of experimental and clinical research.

Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes

K. Kotoh, E. Kajiwara, N. Yamashita, 2014, Journal of Gastroenterology.

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake

K. Kotoh, M. Nakashima, M. Nakamuta, 2012, Gastroenterology research and practice.

Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of viral hepatitis.

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

H. Nomura, J. Hayashi, K. Kotoh, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non‐cirrhotic patients with chronic hepatitis C virus genotype 1b infection

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of gastroenterology and hepatology.

Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy.

K. Kotoh, M. Nakashima, M. Nakamuta, 2013, World journal of gastrointestinal pharmacology and therapeutics.

Prevalence of hepatitis B or C virus infections in patients with non‐Hodgkin's lymphoma

N. Kinukawa, S. Inaba, K. Kotoh, 2001, Journal of gastroenterology and hepatology.

Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis.

K. Kotoh, M. Nakamuta, M. Kohjima, 2012, Experimental and therapeutic medicine.

Comparative safety study on severe anemia by simeprevir versus telaprevir‐based triple therapy for chronic hepatitis C

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of gastroenterology and hepatology.

Local recurrence is an important prognostic factor of hepatocellular carcinoma.

K. Kotoh, H. Nawata, M. Nakamuta, 2005, World journal of gastroenterology.

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.

Y. Maehara, K. Kotoh, M. Nakashima, 2008, International journal of molecular medicine.

Leptin response in patients undergoing interferon therapy.

K. Kotoh, H. Sakai, H. Nawata, 2002, Journal of clinical gastroenterology.

Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats.

K. Kotoh, R. Takayanagi, M. Nakamuta, 2014, World journal of gastroenterology.

Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism.

K. Kotoh, R. Takayanagi, Kazuhiko Nakamura, 2011, Molecular medicine reports.

Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease.

K. Kotoh, R. Takayanagi, M. Nakamuta, 2011, Experimental and therapeutic medicine.

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

K. Kotoh, M. Nakashima, M. Nakamuta, 2010, Lipids in Health and Disease.

Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.

Y. Maehara, K. Kotoh, M. Nakashima, 2009, International journal of molecular medicine.

SREBP-1 c , regulated by the insulin and AMPK signaling pathways , plays a role in nonalcoholic fatty liver disease

K. Kotoh, R. Takayanagi, M. Nakamuta, 2022 .

The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells

K. Kotoh, M. Nakashima, M. Nakamuta, 2009, In Vitro Cellular & Developmental Biology - Animal.

A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?

K. Kotoh, T. Ohashi, R. Takayanagi, 2013, Clinical Journal of Gastroenterology.

Expression profiles of genes associated with viral entry in HCV‐infected human liver

Y. Maehara, K. Kotoh, M. Nakashima, 2011, Journal of medical virology.

Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE.

K. Kotoh, H. Nawata, M. Nakamuta, 2005, World journal of gastroenterology.

Adipose differentiation related protein induces lipid accumulation and lipid droplet formation in hepatic stellate cells

K. Kotoh, H. Nawata, S. Ohta, 2005, In Vitro Cellular & Developmental Biology - Animal.

Spalt‐like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma

Y. Maehara, K. Shirabe, K. Kotoh, 2016, Histopathology.

The prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: the influence of liver fibrosis.

K. Kotoh, A. Masumoto, M. Nakamuta, 2016, Journal of gastrointestinal oncology.

High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis.

K. Kotoh, H. Sakai, H. Nawata, 2005, World journal of gastroenterology.

Antithrombin III injection via the portal vein suppresses liver damage.

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2012, World journal of gastroenterology.

Deteriorated portal flow may cause liver failure in patients with hepatocellular carcinoma being treated with sorafenib.

K. Kotoh, Masaki Kato, S. Harada, 2016, Journal of gastrointestinal oncology.

Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas

K. Kotoh, M. Nakashima, K. Yamaguchi, 2005, Journal of gastroenterology and hepatology.

Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism

Y. Maehara, K. Shirabe, K. Kotoh, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Effect of IL‐4 and IL‐13 on collagen production in cultured LI90 human hepatic stellate cells

K. Kotoh, H. Nawata, S. Ohta, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Fasudil hydrochloride hydrate, a Rho‐kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

K. Kotoh, N. Kobayashi, H. Nawata, 2005, Liver international : official journal of the International Association for the Study of the Liver.

A high prevalence of extreme hyperferritinemia in acute hepatitis patients

K. Kotoh, R. Takayanagi, M. Nakamuta, 2009, Hepatic medicine : evidence and research.

Clinical significance of serum levels of vascular endothelial growth factor and its receptor in biliary disease and carcinoma.

K. Kotoh, Masao Tanaka, H. Nawata, 2005, World journal of gastroenterology.

Telaprevir‐based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study

H. Nomura, J. Hayashi, K. Kotoh, 2013, Alimentary pharmacology & therapeutics.

An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

H. Nomura, J. Hayashi, K. Kotoh, 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure.

K. Kotoh, R. Takayanagi, Kazuhiko Nakamura, 2011, Experimental and therapeutic medicine.

Contrast‐enhanced ultrasonography using Sonazoid to evaluate changes in hepatic hemodynamics in acute liver injury

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2011, Journal of gastroenterology and hepatology.

Efficacy and safety of splenectomy in telaprevir‐based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis

H. Nomura, J. Hayashi, Y. Maehara, 2014, Journal of gastroenterology and hepatology.

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

K. Kotoh, M. Nakamuta, M. Kohjima, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Adipose differentiation related protein induces lipid accumulation and lipid droplet formation in hepatic stellate cells

K. Kotoh, H. Nawata, S. Ohta, 2005, In Vitro Cellular & Developmental Biology - Animal.

Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.

K. Kotoh, N. Kobayashi, S. Ohta, 2005, The Journal of laboratory and clinical medicine.

The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract.

K. Kotoh, I. Choi, H. Nawata, 2002, Journal of hepatology.

Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma.

K. Sugimachi, K. Kotoh, M. Tsuneyoshi, 2001, Cancer letters.

Beraprost sodium, a prostacyclin (PGI2) analogue, ameliorates concanavalin A‐induced liver injury in mice

K. Kotoh, H. Nawata, S. Ohta, 2005, Liver international : official journal of the International Association for the Study of the Liver.

) analogue, ameliorates concanavalin A-induced liver injury in mice

K. Kotoh, S. Ohta, H. Nawata, 2005 .

Soluble Arg-Gly-Asp Peptides Reduce Collagen Accumulation in Cultured Rat Hepatic Stellate Cells

K. Kotoh, H. Sakai, H. Nawata, 1999, Digestive Diseases and Sciences.

Long-term fibrate treatment for PBC

K. Kotoh, M. Nakamuta, M. Enjoji, 2005, Journal of Gastroenterology.

Serum levels of soluble molecules associated with evasion of immune surveillance: a study in biliary disease

K. Kotoh, Masao Tanaka, H. Nawata, 2004, Liver international : official journal of the International Association for the Study of the Liver.

Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d‐galactosamine

K. Kotoh, R. Takayanagi, S. Aishima, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Pruritus in Chronic Liver Disease: A Questionnaire Survey on 216 Patients.

J. Hayashi, K. Kotoh, N. Furusyo, 2019, Acta dermato-venereologica.

Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infection.

H. Nomura, J. Hayashi, K. Kotoh, 2015, Internal medicine.

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients

H. Nomura, J. Hayashi, K. Kotoh, 2007, Comparative hepatology.

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma

K. Kotoh, A. Masumoto, M. Kohjima, 2017, World journal of gastroenterology.

Primary hepatic lymphoma in a patient with Sjögren's syndrome

K. Kotoh, H. Sakai, H. Nawata, 2002, Journal of Gastroenterology.

Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells.

K. Kotoh, N. Kobayashi, S. Ohta, 2005, International journal of molecular medicine.

Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway.

Y. Maehara, K. Kotoh, T. Nishinakagawa, 2010, International journal of clinical pharmacology and therapeutics.

Re-evaluation of antitumor effects of combination chemotherapy with interferon-alpha and 5-fluorouracil for advanced hepatocellular carcinoma.

K. Kotoh, M. Nakamuta, M. Kohjima, 2005, World journal of gastroenterology.

Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C

Y. Maehara, K. Shirabe, K. Kotoh, 2013, Hepatology International.

Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma.

K. Kotoh, M. Nakamuta, M. Kohjima, 2005, World journal of gastroenterology.

Lemierre's syndrome: Porphyromonas asaccharolytica as a putative pathogen.

K. Kotoh, H. Nawata, M. Nakamuta, 2005, Internal medicine.

Relationship between body surface area and ALT normalization after long-term lamivudine treatment.

H. Nomura, J. Hayashi, K. Kotoh, 2005, World journal of gastroenterology.

Beta-lipoproteins influence the serum level of hepatitis C virus.

N. Kinukawa, K. Kotoh, H. Nawata, 2000, Medical science monitor : international medical journal of experimental and clinical research.

A novel tumour marker RCAS1 in a case of extramammary Paget's disease

K. Kotoh, M. Nakashima, M. Nakamuta, 2003, Clinical and experimental dermatology.

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

K. Kotoh, R. Takayanagi, M. Nakamuta, 2007, International journal of molecular medicine.

Prognostic Factors of Computed Tomography Findings in Patients with Severe Acute Hepatic Failure Scheduled to Undergo Transcatheter Arterial Steroid Injection Therapy

H. Honda, A. Nishie, Y. Asayama, 2019, Interventional Radiology.

Radiological catheter placement for transcatheter arterial steroid injection therapy to treat severe acute hepatic failure: technical feasibility and efficacy

H. Honda, A. Nishie, Y. Ushijima, 2012, Acta radiologica.

Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure.

Y. Asayama, K. Kotoh, M. Nakamuta, 2006, World journal of gastroenterology.

Three cases of acute fatty liver of pregnancy: Postpartum clinical course depends on interval between onset of symptoms and termination of pregnancy

K. Kotoh, N. Wake, K. Fukushima, 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Early extensive viremia, but not rs8099917 genotype, is the only predictor for cholestatic hepatitis C after living‐donor liver transplantation

Y. Maehara, K. Shirabe, K. Kotoh, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A retrospective study

Ryoichi Takayanagi, Masaki Kato, K. Kotoh, 2008, Comparative hepatology.

Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2015, World journal of hepatology.

Impact of conversion from pegylated interferon-α2b to interferon-α2a for treating recurrent hepatitis C after liver transplantation.

Y. Maehara, K. Shirabe, K. Kotoh, 2013, Transplantation.

Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C.

K. Kotoh, T. Ohashi, Tsukasa Nakamura, 2016, Experimental and therapeutic medicine.

Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases.

K. Kotoh, H. Nawata, M. Nakashima, 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma.

N. Kinukawa, K. Kotoh, H. Nawata, 2003, Journal of hepatology.

RCAS1 expression in immune-mediated liver diseases.

K. Kotoh, H. Nawata, M. Nakashima, 2002, Journal of clinical gastroenterology.

CASE REPORT: RCAS1, a Useful Serum Marker to Predict the Recurrence of Cancer: Two Cases of Cholangiocarcinoma and Pancreatic Cancer

K. Kotoh, Masao Tanaka, H. Nawata, 2004, Digestive Diseases and Sciences.

RCAS1‐expressing macrophages in inflammatory liver diseases

K. Kotoh, M. Nakashima, M. Nakamuta, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC.

K. Shirabe, K. Kotoh, R. Takayanagi, 2013, Molecular medicine reports.

Transient multiple hepatic nodules with marked infiltration of eosinophils caused by ascariasis.

K. Kotoh, A. Masumoto, M. Otsuki, 1997, The American journal of gastroenterology.

Acute Pancreatitis and Cholecystitis Associated with Postpartum HELLP Syndrome: A Case and Review

K. Kotoh, M. Nozaki, K. Tsukimori, 2007, Hypertension in pregnancy.

Endoscopic approach through the minor papilla for the management of pancreatic diseases.

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2013, World journal of gastrointestinal endoscopy.

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α‐2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study

H. Nomura, J. Hayashi, K. Kotoh, 2012, Journal of gastroenterology and hepatology.

Acute liver failure caused by drug-induced hypersensitivity syndrome associated with hyperferritinemia.

K. Kotoh, R. Takayanagi, M. Nakamuta, 2011, World journal of gastroenterology.

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

Remote delivery and expression of soluble type II TGF-beta receptor in muscle prevents hepatic fibrosis in rats.

K. Kotoh, M. Nakamuta, M. Kohjima, 2005, International journal of molecular medicine.

Various sarcoid lesions in a patient induced by interferon therapy for chronic hepatitis C.

K. Kotoh, H. Nawata, M. Nakamuta, 2002, Journal of clinical gastroenterology.

Hepatopancreatobiliary manifestations of inflammatory bowel disease

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2012, Clinical Journal of Gastroenterology.

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression

Y. Maehara, K. Kotoh, M. Nakashima, 2009, Hepatology international.

Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2010, World journal of gastroenterology.

Add‐on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C

N. Sakamoto, K. Kotoh, Yasuhito Tanaka, 2013, Journal of medical virology.

Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments

K. Kotoh, M. Nakamuta, M. Kohjima, 2012, International journal of hepatology.

A multi‐step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra‐tumor pressure and to reduce the ablation time

Hajime Nawata, K. Kotoh, H. Sakai, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

K. Kotoh, R. Takayanagi, M. Nakamuta, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

An adult case with Hunter's syndrome presenting prominent hepatic failure: light and electron microscopic features of the liver.

K. Kotoh, H. Sakai, M. Nakamuta, 2006, Internal medicine.

Pruritus in chronic liver disease: a questionnaire survey in 71 patients

J. Hayashi, K. Kotoh, N. Furusyo, 2016 .

Fas antigen expression on hepatocytes predicts the short- and long-term response to interferon therapy in patients with chronic hepatitis C.

K. Kotoh, M. Otsuki, S. Abe, 2001, Scandinavian journal of gastroenterology.

[Frequency of gastroesophageal reflux disease (GERD) as a complication in patients with chronic liver diseases: estimation of frequency scale for the system of GERD].

K. Kotoh, R. Takayanagi, M. Nakamuta, 2007, Fukuoka igaku zasshi = Hukuoka acta medica.

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

Expression profile of lipid metabolism‐associated genes in hepatitis C virus‐infected human liver

Y. Maehara, K. Kotoh, M. Nakashima, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma.

K. Kotoh, H. Sakai, M. Nakamuta, 2005, World journal of gastroenterology.

[Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].

K. Kotoh, H. Nawata, M. Nakamuta, 2004, Fukuoka igaku zasshi = Hukuoka acta medica.

The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy.

K. Kotoh, M. Satoh, H. Sakai, 1994, The American journal of gastroenterology.

The use of percutaneous ethanol injection therapy for recurrence of hepatocellular carcinoma.

K. Kotoh, H. Sakai, H. Nawata, 1995, Hepato-gastroenterology.

Self-regulation of type I collagen degradation by collagen-induced production of matrix metalloproteinase-1 on cholangiocarcinoma and hepatocellular carcinoma cells

K. Kotoh, H. Nawata, M. Nakamuta, 2000, In Vitro Cellular & Developmental Biology - Animal.

Pegylated interferon α‐2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase

H. Nomura, J. Hayashi, K. Kotoh, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Cyclosporine suppresses cell growth and collagen production in hepatic stellate cells.

K. Kotoh, N. Kobayashi, M. Nakamuta, 2005, Transplantation proceedings.

[Five adult cases of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].

K. Kotoh, R. Takayanagi, S. Ohga, 2010, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Evaluation of liver parenchymal pressure and portal endothelium damage during radio frequency ablation in an in vivo porcine model

K. Kotoh, H. Sakai, M. Nakamuta, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Dimethyl sulfoxide inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.

K. Kotoh, S. Ohta, H. Nawata, 2001, International journal of molecular medicine.

Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma

K. Kotoh, M. Harada, Ryoichi Narita, 2020, AntiCancer Research.

Relationship between pancreatic and/or extrapancreatic lesions and serum IgG and IgG4 levels in IgG4‐related diseases

K. Kotoh, R. Takayanagi, Tetsuhide Ito, 2012, Journal of digestive diseases.

Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods

K. Kotoh, H. Sakai, M. Nakamuta, 2006, Comparative hepatology.

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry

H. Honda, Y. Takayama, A. Nishie, 2016, World journal of gastroenterology.

Successful control of hemobilia secondary to metastatic liver cancer with transcatheter arterial embolization.

K. Kotoh, M. Satoh, H. Nawata, 1991, The American journal of gastroenterology.

Long‐term prognosis and prognostic factors of liver cirrhosis in the 1980s

Y. Nose, K. Kotoh, H. Sakai, 1994, Journal of gastroenterology and hepatology.

Clinical Significance of Urinary N1,N12-Diacetylspermine Levels in Patients with Hepatocellular Carcinoma

K. Kotoh, H. Nawata, M. Nakamuta, 2004 .

Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma.

K. Kotoh, H. Nawata, M. Nakamuta, 2004, The International journal of biological markers.

Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.

K. Kotoh, Tsukasa Nakamura, Susumu Koyama, 2015, World journal of gastroenterology.

Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy?

Y. Maehara, K. Kotoh, T. Nishinakagawa, 2009, International journal of molecular medicine.

Investigation of hyperuricemia during pegylated‐interferon‐α2b plus ribavirin combination therapy in patients with chronic hepatitis C

N. Kinukawa, K. Kotoh, R. Takayanagi, 2008, Journal of digestive diseases.

Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs

K. Kotoh, M. Nakamuta, M. Kohjima, 2007, Liver international : official journal of the International Association for the Study of the Liver.

BISPHENOL A DIGLYCIDYL ETHER (BADGE) SUPPRESSES TUMOR NECROSIS FACTOR‐α PRODUCTION AS A PPARγ AGONIST IN THE MURINE MACROPHAGE‐LIKE CELL LINE, RAW 264.7

K. Kotoh, H. Nawata, S. Ohta, 2002 .

Regorafenib could cause sinusoidal obstruction syndrome.

K. Kotoh, H. Orita, Masaki Kato, 2016, Journal of gastrointestinal oncology.

Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes.

N. Sakamoto, K. Kotoh, T. Nishinakagawa, 2011, International journal of molecular medicine.

Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism

Y. Maehara, K. Shirabe, K. Kotoh, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats.

K. Kotoh, H. Nawata, K. Egashira, 2004, International journal of molecular medicine.